Brief: Aquestive Therapeutics Inc Files For Resale Of Up To 2.75 Million Shares Of Common Stock By The Selling Stockholder
21/09/2023 11:16
Sept 21 (Reuters) - Aquestive Therapeutics Inc AQST.O :
* AQUESTIVE THERAPEUTICS INC FILES FOR RESALE OF UP TO 2.75
MILLION SHARES OF COMMON STOCK BY THE SELLING STOCKHOLDER - SEC
FILING
Source text: [ID:https://encr.pw/Cm4vP]
Further company coverage: AQST.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aquestive Therapeutics
See all newsBrief: Aquestive Therapeutics Inc - Enters Five-Year Term Loan Facility Of Up To $150 Million On May 12, 2026 - SEC Filing
Aquestive Therapeutics Q1 revenue jumps on higher license and royalty income
Brief: Aquestive Therapeutics Announces Completion Of Type A Meeting With FDA For Anaphylm™ (Dibutepinephrine) Sublingual Film
Aquestive misses Q4 revenue estimates, EBITDA loss widens
Brief: Aquestive Therapeutics, Inc. Q4 Net Income USD -31.86 Million